These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Unequal impact of age, percentage body fat, and serum testosterone concentrations on the somatotrophic, IGF-I, and IGF-binding protein responses to a three-day intravenous growth hormone-releasing hormone pulsatile infusion in men. Iranmanesh A, South S, Liem AY, Clemmons D, Thorner MO, Weltman A, Veldhuis JD. Eur J Endocrinol; 1998 Jul; 139(1):59-71. PubMed ID: 9703380 [Abstract] [Full Text] [Related]
27. Growth hormone-releasing hormone infusion in patients with active acromegaly. Losa M, Chiodini PG, Liuzzi A, König A, Müller OA, Schopohl J, von Werder K. J Clin Endocrinol Metab; 1986 Jul; 63(1):88-93. PubMed ID: 3086362 [Abstract] [Full Text] [Related]
31. Pyridostigmine treatment selectively amplifies the mass of GH secreted per burst without altering GH burst frequency, half-life, basal GH secretion or the orderliness of GH release. Friend K, Iranmanesh A, Login IS, Veldhuis JD. Eur J Endocrinol; 1997 Oct; 137(4):377-86. PubMed ID: 9368506 [Abstract] [Full Text] [Related]